Sort
50,496 grants matching “lung cancer”
Community Clinical Oncology Program
$400,119Northshore Univ Healthsystem Res Inst · U10 · FY2004 · CA
Intracellular Domain Elements in the Regulation of EGF Receptor Kinase Activity
$400,094Graham F Carpenter · Vanderbilt University · R01 · FY2009 · GM
MARC/Biomedical Research and Training Program at the University of Arizona
$400,086Marc E Tischler · University Of Arizona · T34 · FY2007 · GM
Establishing the clinical utility of cell-free tumor DNA methylation profiling as a reliable liquid biopsy approach in brain tumors
$400,069Gelareh Zadeh · University Health Network · R01 · FY2023 · CA
Rapid Protease Profiling with a Multiplex Electronic Method for Detection of Metastatic Triple-Negative Breast Cancer
$400,057Jun Li · Kansas State University · R01 · FY2017 · CA
CAREER: Stochastic Models of Cancer Evolution
$400,054Jasmine Y Foo · University Of Minnesota-Twin Cities · · FY2014 · MPS
Targeting metastatic tumors with engineered cellular therapies
$400,053Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2025 · CA
BIOMAKERS IN LUNG CARCINOMA AND PREMALIGNACY
$400,033University Of Colorado Denver · U01 · FY2003 · CA
Inhibitor of Adrenal Steroid Synthesis for Cancer Treatment
$400,027Scott McNear Thacher · Orphagen Pharmaceuticals · R43 · FY2010 · CA
PLACENTAL CURATED RESEARCH DATASET
$400,025Lydia Rogers · Social And Scientific Systems, Inc. · N02 · FY2018 · HD
Ventricular Remodeling in the Adapted Heart
$400,007Nilanjana Maulik · University Of Connecticut Sch Of Med/Dnt · R01 · FY2012 · HL
Development of Anti-EGFR-huEndo-P125A: A combined Vasculogenic Mimicry-Angiogenesis inhibitory therapeutic for Triple Negative Breast Cancer
$400,000Rathin C Das · Synergys Biotherapeutics, Inc. · R44 · FY2022 · CA
Regulation and function of nonlymphoid organ CD103 dendritic cells
$400,000Stephanie S Watowich · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · AI
Non-invasive detection of tumor NTRK gene fusions via rapid, efficient and low-cost extracellular vesicle isolation method
$400,000Hongzhang He · Captis Diagnostics · R43 · FY2023 · CA
Development of drug conjugates of R-spondin peptibodies for the treatment of colorectal cancer
$400,000Jie Cui · Wntrix, Inc. · R41 · FY2023 · CA
Engineered TCR-T Cell Therapy Targeting Driver Mutations in NSCLC
$400,000Matthew James Spindler · Gigamune, Inc. · R43 · FY2021 · CA
Development of polymeric synthetic biomaterial IP-001 to potentiate asystemic immunotherapy of hepatocellular carcinoma via thermal ablation
$400,000Siu Kit Lam · Immunophotonics, Inc. · R44 · FY2021 · CA
P5 - P-53-Based Vaccine for Small Cell Lung Cancer
$400,000Dmitry Isaac Gabrilovich · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2012 · CA
University of New Mexico Cancer Center Support Grant
$400,000Cheryl L Willman · University Of New Mexico Health Scis Ctr · P30 · FY2019 · CA
A novel MICA/B based tumor-centric bispecific antibody that enhances NK cell activity in a hostile tumor microenvironment
$400,000Hemanta Baruah · Aakha Biologics Inc. · R43 · FY2024 · CA
Development of a radiation-activatable nanoparticle for lung cancer therapy
$400,000Zhi Liu · Athna Biotech, Inc. · R41 · FY2021 · CA
Magnet for a 7T Small Animal MRI System
$400,000Thomas T Liu · University Of California, San Diego · S10 · FY2011 · RR
SIRPant Technology for anti-Cancer Immunity
$400,000Nathanael McCurley · Sirpant Immunotherapeutics, Inc. · R42 · FY2021 · CA
Bioengineering 3-D Models for Organ-Specific Cancer Therapy in Lung and Breast
$400,000Mina J Bissell · University Of Calif-Lawrenc Berkeley Lab · U54 · FY2006 · CA
Treating non-small cell lung tumors with a novel inhaled dry powder chemotherapeutic formulation
$400,000Bryce Beverlin II · Quench Medical, Inc. · R43 · FY2020 · CA